Live Marvell Technology Vote →

Never Miss Important Company Updates Again

Get AI-powered summaries of SEC filings delivered to your inbox

Follow your favorite stocks and get email alerts when they release important updates. Completely free.

Covers 5,000+ public companies
Get started →
Sign up to stay up to date with the stocks you care about
Follow Lantheus Holdings, Inc.

Get SEC filing alerts via email and in your feed for Lantheus Holdings, Inc.

LNTH

Lantheus Holdings, Inc.

About Lantheus Holdings, Inc.

Lantheus Holdings, Inc. is a leading provider of radiopharmaceuticals and diagnostic imaging products. Its core activities include developing, manufacturing, and marketing radiopharmaceuticals for oncology and cardiology, such as PYLARIFY and DEFINITY. The company serves healthcare providers worldwide, offering products that improve disease detection, characterization, and patient outcomes through advanced imaging and therapeutic solutions. Its business model combines product sales, strategic partnerships, and clinical development.
This description was generated via AI from an annual report. Updated 8 months ago.

Latest SEC Filings from Lantheus Holdings, Inc.

1
1
Lantheus Holdings, Inc. Lantheus Holdings Reports $377.3 Million Revenue and $118.4 Million Net Income in Q1 2026

Via official filing (AI summary) | 29 days ago | 0 comments

2
1
Lantheus Holdings, Inc. Lantheus Holdings Reports $1.542 Billion in Revenue for 2025, Net Income Declines 25.2%

Via official filing (AI summary) | 3 months ago | 0 comments

3
1
Lantheus Holdings, Inc. Lantheus Holdings Reports Q3 2025 Revenue of $384M, Net Income Declines 78.8%

Via official filing (AI summary) | 7 months ago | 0 comments

4
1
Lantheus Holdings, Inc. Lantheus Holdings Reports Q2 2025 Revenue Decline, Net Income Increase

Via official filing (AI summary) | 10 months ago | 0 comments

5
1
Lantheus Holdings, Inc. Lantheus Holdings Reports Revenue Increase but Net Income Declines in Q1 2025

Via official filing (AI summary) | about 1 year ago | 0 comments

6
1
Lantheus Holdings, Inc. Lantheus Holdings Reports 18.4% Revenue Growth to $378.7 Million in Q3 2024

Via official filing (AI summary) | over 1 year ago | 0 comments